| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adipose-derived mesenchymal stem cells and extracellular vesicles confer antitumor activity in preclinical treatment of breast cancer
|
Li, Tao
|
|
|
157 |
C |
p.
|
artikel
|
| 2 |
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium
|
Cappetta, Donato
|
|
|
157 |
C |
p.
|
artikel
|
| 3 |
An efficient controlled release strategy for hypertension therapy: Folate-mediated lipid nanoparticles for oral peptide delivery
|
Li, Jinhua
|
|
|
157 |
C |
p.
|
artikel
|
| 4 |
Antioxidant modulation of sirtuin 3 during acute inflammatory pain: The ROS control
|
Ilari, Sara
|
|
|
157 |
C |
p.
|
artikel
|
| 5 |
Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy
|
Wang, Enyu
|
|
|
157 |
C |
p.
|
artikel
|
| 6 |
Candidate drugs against SARS-CoV-2 and COVID-19
|
McKee, Dwight L.
|
|
|
157 |
C |
p.
|
artikel
|
| 7 |
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
|
Alves, Patrícia
|
|
|
157 |
C |
p.
|
artikel
|
| 8 |
CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma
|
Gao, Yanan
|
|
|
157 |
C |
p.
|
artikel
|
| 9 |
Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
|
Yang, Ruocong
|
|
|
157 |
C |
p.
|
artikel
|
| 10 |
Current targeted therapeutics against COVID-19: Based on first-line experience in China
|
Zhang, Yue
|
|
|
157 |
C |
p.
|
artikel
|
| 11 |
Darunavir does not prevent SARS-CoV-2 infection in HIV patients
|
Riva, Agostino
|
|
|
157 |
C |
p.
|
artikel
|
| 12 |
Dietary carotenoids in cancer chemoprevention and chemotherapy: A review of emerging evidence
|
Saini, Ramesh Kumar
|
|
|
157 |
C |
p.
|
artikel
|
| 13 |
Editorial Board
|
|
|
|
157 |
C |
p.
|
artikel
|
| 14 |
Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis
|
Zhong, Han
|
|
|
157 |
C |
p.
|
artikel
|
| 15 |
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020
|
Zheng, Yi
|
|
|
157 |
C |
p.
|
artikel
|
| 16 |
Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction?
|
Manduca, Joshua D.
|
|
|
157 |
C |
p.
|
artikel
|
| 17 |
18β-Glycyrrhetinic acid acts through hepatocyte nuclear factor 4 alpha to modulate lipid and carbohydrate metabolism
|
Yang, Meng
|
|
|
157 |
C |
p.
|
artikel
|
| 18 |
Granulocyte-targeted therapies for airway diseases
|
Tavares, Luciana P.
|
|
|
157 |
C |
p.
|
artikel
|
| 19 |
Knockout of macrophage migration inhibitory factor accentuates side-stream smoke exposure-induced myocardial contractile dysfunction through dysregulated mitophagy
|
Wang, Shuyi
|
|
|
157 |
C |
p.
|
artikel
|
| 20 |
Mangiferin activates Nrf2 to attenuate cardiac fibrosis via redistributing glutaminolysis-derived glutamate
|
Song, Junna
|
|
|
157 |
C |
p.
|
artikel
|
| 21 |
Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission
|
Liang, Xinyue
|
|
|
157 |
C |
p.
|
artikel
|
| 22 |
Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management
|
Kelleni, Mina T.
|
|
|
157 |
C |
p.
|
artikel
|
| 23 |
Novel use for old drugs: The emerging role of artemisinin and its derivatives in fibrosis
|
Wang, Youke
|
|
|
157 |
C |
p.
|
artikel
|
| 24 |
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
|
Capuano, Annalisa
|
|
|
157 |
C |
p.
|
artikel
|
| 25 |
Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor
|
Li, Yanwei
|
|
|
157 |
C |
p.
|
artikel
|
| 26 |
Placenta-targeted treatment strategies: An opportunity to impact fetal development and improve offspring health later in life
|
Ganguly, Esha
|
|
|
157 |
C |
p.
|
artikel
|
| 27 |
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
|
Habtemariam, Solomon
|
|
|
157 |
C |
p.
|
artikel
|
| 28 |
Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder
|
Wang, Ying
|
|
|
157 |
C |
p.
|
artikel
|
| 29 |
Reply to “The use of traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good”
|
Zhang, Ai-Hua
|
|
|
157 |
C |
p.
|
artikel
|
| 30 |
Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
|
Maggio, Roberto
|
|
|
157 |
C |
p.
|
artikel
|
| 31 |
Stress-induced blood brain barrier disruption: Molecular mechanisms and signaling pathways
|
Welcome, Menizibeya O.
|
|
|
157 |
C |
p.
|
artikel
|
| 32 |
Structure and function of USP5: Insight into physiological and pathophysiological roles
|
Ning, Fengling
|
|
|
157 |
C |
p.
|
artikel
|
| 33 |
Targeting of endoplasmic reticulum (ER) stress in gliomas
|
Markouli, Mariam
|
|
|
157 |
C |
p.
|
artikel
|
| 34 |
Targeting the microbiota in pharmacology of psychiatric disorders
|
Pascale, Alessia
|
|
|
157 |
C |
p.
|
artikel
|
| 35 |
Tetrahydrobiopterin in energy metabolism and metabolic diseases
|
Kim, Hyoung Kyu
|
|
|
157 |
C |
p.
|
artikel
|
| 36 |
The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
|
Zhang, Dan
|
|
|
157 |
C |
p.
|
artikel
|
| 37 |
The CoV-2 outbreak: how hematologists could help to fight Covid-19
|
Galimberti, Sara
|
|
|
157 |
C |
p.
|
artikel
|
| 38 |
The functional link between microsomal prostaglandin E synthase-1 (mPGES-1) and peroxisome proliferator-activated receptor γ (PPARγ) in the onset of inflammation
|
Maione, Francesco
|
|
|
157 |
C |
p.
|
artikel
|
| 39 |
The interactions between gut microbiota and bioactive ingredients of traditional Chinese medicines: A review
|
Gong, Xue
|
|
|
157 |
C |
p.
|
artikel
|
| 40 |
The pros and cons of traditional Chinese medicines in the treatment of COVID-19
|
Wang, Yali
|
|
|
157 |
C |
p.
|
artikel
|
| 41 |
What intervention regimen is most effective prevention for Portal venous system thrombosis after splenectomy in cirrhotics patients with Portal hypertension? Systematic review and network meta-analysis
|
Ding, Hongda
|
|
|
157 |
C |
p.
|
artikel
|
Tijdschrift beschrijving